The role of porcine factor VIII in the management of unexpected bleeding episodes

L. M. Aledort

doi:10.1046/j.1365-2516.2002.00578.x

The role of porcine factor VIII in the management of unexpected bleeding episodes

L. M. Aledort

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Abstract

The introduction of porcine factor VIII (pFVIII) has been an important addition to our armamentarium in the management of patients with inhibitors to FVIII. Case studies will be presented that offer important differential diagnoses. The prevalence and indications for the use of this biological replacement therapy will be discussed.

Original language	English
Pages (from-to)	17-19
Number of pages	3
Journal	Haemophilia
Volume	8
Issue number	SUPPL. 1
DOIs	https://doi.org/10.1046/j.1365-2516.2002.00578.x
State	Published - 2002

Keywords

Bleeding
Factor VIII
Inhibitors
Porcine factor VIII

Access to Document

10.1046/j.1365-2516.2002.00578.x

Cite this

@article{31e70cf9bea54e26a0a30efa97cba4b3,

title = "The role of porcine factor VIII in the management of unexpected bleeding episodes",

abstract = "The introduction of porcine factor VIII (pFVIII) has been an important addition to our armamentarium in the management of patients with inhibitors to FVIII. Case studies will be presented that offer important differential diagnoses. The prevalence and indications for the use of this biological replacement therapy will be discussed.",

keywords = "Bleeding, Factor VIII, Inhibitors, Porcine factor VIII",

author = "Aledort, \{L. M.\}",

year = "2002",

doi = "10.1046/j.1365-2516.2002.00578.x",

language = "English",

volume = "8",

pages = "17--19",

journal = "Haemophilia",

issn = "1351-8216",

publisher = "John Wiley and Sons Inc.",

number = "SUPPL. 1",

}

TY - JOUR

T1 - The role of porcine factor VIII in the management of unexpected bleeding episodes

AU - Aledort, L. M.

PY - 2002

Y1 - 2002

N2 - The introduction of porcine factor VIII (pFVIII) has been an important addition to our armamentarium in the management of patients with inhibitors to FVIII. Case studies will be presented that offer important differential diagnoses. The prevalence and indications for the use of this biological replacement therapy will be discussed.

AB - The introduction of porcine factor VIII (pFVIII) has been an important addition to our armamentarium in the management of patients with inhibitors to FVIII. Case studies will be presented that offer important differential diagnoses. The prevalence and indications for the use of this biological replacement therapy will be discussed.

KW - Bleeding

KW - Factor VIII

KW - Inhibitors

KW - Porcine factor VIII

UR - https://www.scopus.com/pages/publications/0036210011

U2 - 10.1046/j.1365-2516.2002.00578.x

DO - 10.1046/j.1365-2516.2002.00578.x

M3 - Article

C2 - 11882078

AN - SCOPUS:0036210011

SN - 1351-8216

VL - 8

SP - 17

EP - 19

JO - Haemophilia

JF - Haemophilia

IS - SUPPL. 1

ER -

The role of porcine factor VIII in the management of unexpected bleeding episodes

Abstract

Keywords

Access to Document

Fingerprint

Cite this